Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Intellia Thera CS (NQ: NTLA )

113.13 USD -2.39 (-2.07%)
Official Closing Price Updated: 2:54 PM EST, Nov 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 494,494
Open 112.18
Bid (Size) 111.26 (5)
Ask (Size) 115.00 (2)
Prev. Close 115.52
Today's Range 111.01 - 117.95
52wk Range 35.61 - 202.73
Shares Outstanding 74,419,414
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Noteworthy Wednesday Option Activity: RUN, BIIB, NTLA
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sunrun Inc (RUN), where a total of 21,388 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
Novartis AG(NYSE: NVS) is getting a massive influx of cash fromselling its 20-year stakeinRoche Holdings ... 
Tags NVS General News
From Benzinga

Performance

YTD
+102.34%
+102.34%
1 Month
-16.88%
-16.88%
3 Month
-26.52%
-26.52%
6 Month
+53.44%
+53.44%
1 Year
+187.28%
+187.28%

More News

Read More
Direxion Launches New Nanotechnology ETF, TYNE
Tags BRKR NTLA BEAM
From ETF Trends
NTLA October 2022 Options Begin Trading
Tags Stocks
From Market News Video
Implied BBH Analyst Target Price: $226
Tags ETFs
From ETF Channel
Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?
Tags Recent Press Releases Market News NTLA
From Motley Fool
IWO, CROX, NTLA, SGMS: Large Outflows Detected at ETF
Tags ETFs
From ETF Channel
Looking for Growth in Small and Mid Cap Life Science Stocks
Tags Market News Stocks / Equities Pharma/Biotech
From TalkMarkets
Intellia Therapeutics, Inc (NTLA) Q3 2021 Earnings Call Transcript
Tags NTLA Market News Recent Press Releases
From Motley Fool
Editas Medicine Could Skyrocket if Its Gene Editing Therapy Proves Successful
Tags NTLA EDIT Market News
From InvestorPlace
EVP And Chief Medical Officer Of Intellia Therapeutics Trades $340K In Company Stock
Tags NTLA Trading Ideas Insider Trades
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.